Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
Background & Aims Non-alcoholic steatohepatitis (NASH) is a chronic, progressive fibrotic
liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study.
M Rinella, JF Dufour, QM Anstee, Z Goodman… - Journal of …, 2022 - boris.unibe.ch
BACKGROUND & AIMS Nonalcoholic steatohepatitis (NASH) is a chronic, progressive
fibrotic liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
fibrotic liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
[引用][C] Noninvasive Evaluation of Response to Obeticholic Acid in Patients with NASH: Results from the REGENERATE Study
M Rinella, JF Dufour, QM Anstee, Z Goodman… - Journal of …, 2022 - eprints.ncl.ac.uk
Noninvasive Evaluation of Response to Obeticholic Acid in Patients with NASH: Results
from the REGENERATE Study - ePrints - Newcastle University Newcastle University Toggle …
from the REGENERATE Study - ePrints - Newcastle University Newcastle University Toggle …
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
ME Rinella, JF Dufour, QM Anstee… - Journal of …, 2022 - journal-of-hepatology.eu
Background & Aims Non-alcoholic steatohepatitis (NASH) is a chronic, progressive fibrotic
liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
ME Rinella, JF Dufour, QM Anstee… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background & aims Non-alcoholic steatohepatitis (NASH) is a chronic, progressive fibrotic
liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study.
ME Rinella, JF Dufour, QM Anstee, Z Goodman… - Journal of …, 2021 - europepmc.org
Methods Patients with NASH and fibrosis stage F2 or F3 (n= 931) were randomized (1: 1: 1)
to receive placebo, OCA 10 mg, or OCA 25 mg once daily. Various NITs based on clinical …
to receive placebo, OCA 10 mg, or OCA 25 mg once daily. Various NITs based on clinical …
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
ME Rinella, JF Dufour, QM Anstee… - Journal of …, 2022 - journal-of-hepatology.eu
Background & Aims Non-alcoholic steatohepatitis (NASH) is a chronic, progressive fibrotic
liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …
liver disease that can lead to cirrhosis. While liver biopsy is considered the reference …